Nick Conley
About Nick Conley
Vice President of Technology
Nick Conley serves as the Vice President of Technology. In this role, he oversees technological developments and initiatives within the organization. His leadership is instrumental in driving the company's innovation and technological advances, leveraging his extensive background and expertise in biotechnology and chemistry.
Co-founder of EpiBiome
Nick Conley co-founded EpiBiome, a venture-backed biotech company. EpiBiome focuses on leveraging bacteriophage technology for therapeutic applications. Under his co-leadership, the company has embarked on significant projects, such as developing advanced biotech solutions aimed at combatting bacterial infections.
Developed Phage Manufacturing Process
Nick Conley played a critical role in developing the platform phage manufacturing process for the world's first clinical trial testing a recombinant bacteriophage therapy. This innovation marks a significant milestone in the field of bacteriophage therapy, showcasing Conley's ability to spearhead pioneering research and development projects.
PhD in Chemistry from Stanford University
Nick Conley earned his PhD in Chemistry from Stanford University. His advanced studies in chemistry provided a strong foundation for his subsequent ventures in biotechnology. While at Stanford, he delved deeply into chemical research, contributing to the field through his scholarly work.
Postdoctoral Work in Developmental Biology
After completing his PhD, Nick Conley remained at Stanford University to pursue postdoctoral work in developmental biology. This experience further broadened his scientific expertise and equipped him with valuable insights into complex biological processes, enhancing his approach to biotechnological innovation.